Shareholders Equity ratio Analysis of Evaxion Biotech AS - Deep Dive


Shareholders Equity of EVAX
Dec-23
-36.69
Very Poor Shareholders Equity
Dec-22
-329.89
Very Poor Shareholders Equity
Growth
88.88
%
Shareholders Equity Analysis of Evaxion Biotech AS
Shareholders Equity Ratio of EVAX rose handsomely by 88.88 % this year.
Shareholders Equity Ratio with value of 84.46 was highest in Year Dec-19 in last Five Years.
Shareholders Equity Ratio with value of -329.89 was lowest in Year Dec-22 in last Five Years.
Latest Shareholders Equity Ratio with value of -36.69 is lower than Average Shareholders Equity of -28.51 in last five years.
Other Shareholders Equity Related Info of EVAX that may interest you.
Evaxion Biotech AS Overview
CodePricePrevious PricePrice ChangeSector
EVAX3.723.83 2.87 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation.    more ..
Shareholders Equity Formula

Shareholders Equity Related Ratios
DebtToEquityRatioReturnOnEquity

Tsr Stability Index
Poor Stability Stock
FY - Historical Shareholders Equity of Evaxion Biotech AS
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
Shareholders Equity-36.69-329.8980.7658.8284.46-10.9486.47
Change88.88 %-508.47 %37.30 %-30.36 %872.33 %-112.65 %
FY Chart of Shareholders Equity of Evaxion Biotech AS


Note : All Data Generated at the End of Trading Hours (EOD Data)